Related Experiment Video
Updated: Feb 28, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Targeting Cholinergic System to Modulate Liver Injury
Ravirajsinh N Jadeja1, Vikrant P Rachakonda2, Sandeep Khurana1,3
1Digestive Health Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, United States.
Abstract:
Over the past few decades, evidence accumulated to indicate that parasympathetic innervation regulates liver injury and regeneration. Liver derives its parasympathetic input via vagus nerve. In animal models, vagus nerve stimulation and transection are frequently used to determine the impact of parasympathetic input on liver injury responses. Such strategies provide limited understanding of postneuronal mechanisms involved in the regulation of liver injury. The hepatic branch of vagus nerve releases acetylcholine (ACh), which activates muscarinic and nicotinic receptors in hepatocytes as well as non-parenchymal cells to modulate cellular functions. Moreover, vagus nerve releases other neurotransmitters such as vasoactive intestinal peptide (VIP), which also modulates liver injury responses and hemodynamics. Therefore, our understanding of the post-neuronal modulation of liver injury in models utilizing vagus nerve activity remains limited. Gene-silencing technologies and pharmacological manipulation of receptor activity have not only improved our understanding of the role of specific cholinergic receptors but also elucidated the role of various liver cell sub-populations in modulating liver injury response. With advent of organ- and cell-specific transgenic mice, our understanding of neural regulation of liver injury is likely to improve further. This review comprehensively provides current understanding of cholinergic regulation of liver injury, and points to potential therapeutic targets to treat liver injury.
Insights
Parasympathetic nerves regulate liver injury and regeneration through acetylcholine release. Understanding these neural pathways offers potential therapeutic targets for liver disease.
Area of Science:
- Hepatology
- Neurogastroenterology
- Cellular Biology
Background:
- Parasympathetic innervation plays a crucial role in regulating liver injury and regeneration.
- The vagus nerve is the primary source of parasympathetic input to the liver.
- Current models often focus on vagal nerve activity, limiting insight into post-neuronal mechanisms.
Purpose of the Study:
- To review the current understanding of cholinergic regulation in liver injury.
- To explore the role of neurotransmitters and cellular receptors in liver pathophysiology.
- To identify potential therapeutic targets for treating liver injury.
Main Methods:
- Review of existing literature on vagus nerve stimulation and transection in animal models.
- Analysis of studies utilizing gene-silencing and pharmacological approaches.
- Consideration of advancements in organ- and cell-specific transgenic mice models.
Main Results:
- Acetylcholine (ACh) released by the hepatic vagus nerve activates muscarinic and nicotinic receptors in liver cells.
- Vasoactive intestinal peptide (VIP) also modulates liver injury and hemodynamics.
- Gene-silencing and pharmacological studies have clarified the roles of specific receptors and liver cell populations.
Conclusions:
- Cholinergic signaling significantly impacts liver injury and regeneration.
- Further research using advanced genetic models will enhance understanding of neural regulation in liver disease.
- Targeting cholinergic pathways presents promising therapeutic avenues for liver injury.
More Related Videos
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Pharmacological Actions

